Cystic neoplasms of the pancreas: problems in differential diagnosis

Am Surg. 1993 Nov;59(11):740-5.

Abstract

From 1970 to 1990 we observed 18 patients with histologically proven pancreatic cystic tumors. The average duration of symptoms prior to diagnosis was 14.1 months. A presumptive diagnosis was made preoperatively in nine patients. CT-guided fine needle cytology performed in three cases correctly showed a benign lesion in one patient and malignancy in two patients. Amylase and tumoral marker levels (CEA, CA19-9) were low in cystic fluid of two patients with cystadenomas who underwent preoperative percutaneous aspiration. Intraoperative biopsy of the cystic wall failed to detect epithelial lining in two cases; one patient had internal drainage for cystadenocarcinoma mistaken for pancreatic pseudocyst. Sixteen patients underwent surgery, two of whom died. Of the seven patients with a malignant condition, resection for cure was performed on three. The preoperative diagnosis of these very rare tumors remains difficult. Fine-needle cytology and cystic fluid examination may be a promising technique, but resection of all suspected lesions, whenever possible, is the procedure of choice for diagnosis and treatment.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amylases / blood
  • Antigens, Tumor-Associated, Carbohydrate / blood
  • Biopsy, Needle
  • Carcinoembryonic Antigen / blood
  • Child
  • Diagnosis, Differential
  • Diagnostic Errors
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Pancreatectomy
  • Pancreatic Cyst / blood
  • Pancreatic Cyst / diagnosis*
  • Pancreatic Cyst / epidemiology
  • Pancreatic Cyst / etiology
  • Pancreatic Cyst / surgery
  • Pancreatic Neoplasms / blood
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / epidemiology
  • Pancreatic Neoplasms / surgery
  • Pancreatic Pseudocyst / blood
  • Pancreatic Pseudocyst / diagnosis*
  • Pancreatic Pseudocyst / epidemiology
  • Pancreatic Pseudocyst / surgery
  • Preoperative Care
  • Radiography, Interventional
  • Risk Factors
  • Survival Rate
  • Tomography, X-Ray Computed

Substances

  • Antigens, Tumor-Associated, Carbohydrate
  • Carcinoembryonic Antigen
  • Amylases